Flo Health vs Doximity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Flo Health is the world's most downloaded women's health app with 70M+ monthly active users; raised $200M Series C in 2023 at a $800M valuation; offers AI-powered period tracking, fertility prediction, pregnancy monitoring, and menopause support;
About
Flo Health is a women''s digital health company founded in 2015 and headquartered in London, United Kingdom. The company operates the world''s most downloaded women''s health app — Flo — which provides AI-powered period tracking, ovulation prediction, fertility insights, pregnancy monitoring, and menopause support. With over 70 million monthly active users across more than 150 countries, Flo is the category leader in femtech by user scale, surpassing competitors including Clue, Natural Cycles, and Ovia Health by a significant margin.
Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.
About
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.